Author Question: According to cognitive developmental theory, an important aspect of heteronomous moral behavior is ... (Read 30 times)

JMatthes

  • Hero Member
  • *****
  • Posts: 578
According to cognitive developmental theory, an important aspect of heteronomous moral behavior is
 
  a. whether one believes the behavior would be observed and punished.
  b. one's identification with a loving parent.
  c. whether one understands that morality is a product of a social contract. d. whether one has been punished by spanking or loss of privileges.

Question 2

Which of the following statement about gender and identity is most accurate?
 
  a. Men emphasize interpersonal commitments more than vocational choice. b. Few gender differences in identity status have been discovered.
  c. Women do not make vocational commitments.
  d. Women are more likely to be characterized as identity foreclosed than men.



lkoler

  • Sr. Member
  • ****
  • Posts: 358
Answer to Question 1

a

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library